动脉粥样硬化是缺血性脑血管病最主要的病理学基础。
Atherosclerosis is the most important pathological basis of ischemic cerebrovascular diseases.
颈动脉粥样硬化是缺血性脑血管病的重要危险因素之一。
Carotid atherosclerosis is one of the important risk factors of ischemic cerebrovascular diseases.
抗血小板疗法是缺血性脑血管病治疗中的主要策略，研究证据最多。
Antiplatelet therapy is a major strategy with a growing body of evidence in management of ischemic cerebrovascular diseases.
结论：海马锥体细胞的迟发性坏死是缺血性脑血管病致痴呆的病理学基础。
CONCLUSION: Delayed necrosis of hippocampal pyramidal cells may be the pathological basis of ischemia cerebral vascular dementia.
高血压，糖尿病，冠心病和缺血性脑血管病等慢性病的有效管理，是社区全科医生的重要工作内容，也是一个比较困难的课题。
It is an important yet a difficult task for family physicians to efficiently manage chronic diseases like hypertension, diabetes, coronary heart diseases and ischemic cerebrovascular diseases.
缺血性脑血管病是严重威胁人们生命健康的常见病、多发病。
Background Ischemic cerebrovascular disease is a kind of common and frequent disease that severely imperils patients' lives.
结论：中央支超微结构的改变可能是缺血性或出血性脑血管病的重要发病基础。
Conclusions: Ultrastructure changes of central branch may be the important pathogenetic basis of ischemic or hemorrhagic cerebrovascular disease.
结论：TTP是评价缺血性脑血管病脑循环状态的一个敏感的检查方法，但应结合DSA检查，对脑缺血进行一个综合评价。
Conclusion TTP is a sensitive method in the evaluation of cerebral ischemic disease. It should combined with DSA and evaluate the cerebral ischemic disease comprehensively.
流行病学及临床观察表明，脂蛋白穴a雪是一个新的脑血管病危险因素，与缺血性脑卒中关系较大。
BACKGROUND It is manifested in epidemiology and clinical observation that lipoprotein a is a new risk factor of cerebrovascular disease and is closely related to cerebral ischemic stroke.
急性缺血性脑血管病是导致人类死亡的三大主要疾病之一，仅次于心脏病及癌症，但却是病残的主要原因。
Acute ischemic cerebrovascular disease is one of the three principal diseases causing people to death in which seconded only to heart disease and cancer, but it is the main reason of disabled people.
代谢综合征是心血管病的危险因素，其与缺血性脑血管病的关系已成为近年来研究的热点。
Metabolic syndrome is a risk factor of cardiovascular diseases, and its relationship with ischemic cerebrovascular diseases has become a topic of general interest in recent years.
基质金属蛋白酶（MMP），尤其是MMP-2和MMP-9，在急性缺血性脑血管病的发病机制中起着重要作用。
Matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, play an important role in the pathogenesis of acute ischemic cerebrovascular diseases.
脑保护是治疗急性缺血性脑血管病的主要策略之一。
Neuroprotection is one of main therapeutic strategies for acute ischemic stroke.
因此，对缺血性脑血管病的防治的研究是关系到人类健康的重大课题。
Therefore, research on the prevention and treatment of ischemic cerebrovascular disease is a major issue of concern for human health.
IMT增厚是动脉粥样硬化的早期表现，与缺血性脑血管病密切相关，也与多种血管危险因素有关，被认为是反映全身动脉粥样硬化性疾病的良好指标。
Thickening of IMT is an early manifestation of atherosclerosis. It closely correlates with the ischemic cerebrovascular disease, and it is also associated with a number of vascular risk factors.
脑缺血后，及时恢复缺血区脑组织的血液供应，尤其是缺血半暗带区的血液供应，对于缺血性脑血管病的治疗与预后意义重大。
To recover blood supply of brain tissue in ischemic region especially in ischemic penumbra in time, it will have great significance in treating and prognosis.
脑缺血后，及时恢复缺血区脑组织的血液供应，尤其是缺血半暗带区的血液供应，对于缺血性脑血管病的治疗与预后意义重大。
To recover blood supply of brain tissue in ischemic region especially in ischemic penumbra in time, it will have great significance in treating and prognosis.
应用推荐